What Is the Chance of Having Another Stroke? Understanding Stroke Recurrence Risk

Dongwon Kim4 views0 reactions

For many stroke survivors, one question continues long after leaving the hospital:

“Could I have another stroke?”

The answer is yes—but the probability is very different from one person to another.

A recurrence estimate should therefore never be interpreted as a prediction that another stroke will happen. It is a probability based on groups of patients with similar characteristics.

Understanding that distinction is essential when interpreting stroke-risk calculators, research studies, and personalized prediction tools.

How Common Is Recurrent Stroke?

Population studies show that recurrent stroke remains an important long-term risk.

A large population-based Rotterdam study followed 1,701 people after a first-ever stroke. Overall, 18.0% experienced a recurrent stroke within 10 years. Importantly, recurrence appeared to decrease in more recent decades: among people whose first stroke occurred between 2010 and 2020, the estimated 10-year recurrence risk was approximately 11%.

That number should not be interpreted as an individual's personal risk. Participants in the study were relatively old—the average age was approximately 80—and recurrence varied considerably across individuals.

The more useful question is therefore not:

“What percentage of stroke survivors have another stroke?”

but:

“What factors influence my particular risk?”

Stroke Recurrence Risk Is Not the Same for Everyone

Researchers have identified many characteristics associated with recurrence.

These can include:

  • Previous stroke or transient ischemic attack

  • High blood pressure

  • Atrial fibrillation

  • Diabetes

  • Abnormal cholesterol levels

  • Smoking

  • Stroke mechanism

  • Vascular disease

  • Kidney disease

  • Certain brain-imaging findings

Some are modifiable. Others are not.

The purpose of identifying these factors is not to create anxiety—it is to determine where prevention may be possible.

The American Heart Association/American Stroke Association guideline emphasizes secondary prevention strategies tailored to the cause of the original stroke, including appropriate management of vascular risk factors and antithrombotic therapy when indicated.

Atrial Fibrillation Can Change the Risk Picture

Atrial fibrillation, or AF, is particularly important because it can allow blood clots to form in the heart and travel to the brain.

Even among patients receiving contemporary treatment, recurrence risk is not eliminated completely.

A 2025 systematic review and meta-analysis involving more than 52,000 patients with AF-related stroke reported annualized recurrent-stroke risks in the range of approximately 3.2% to 6.5% across the included studies. Factors associated with recurrence included sustained AF, hyperlipidemia, chronic kidney disease, previous infarcts, and several cardiac and imaging markers.

This is one reason determining the cause of the first stroke is so important for secondary prevention.

Brain Imaging Can Add Information

Stroke recurrence estimation is becoming increasingly sophisticated.

It is no longer based only on age, blood pressure, and medical history.

A 2025 meta-analysis of 50 studies involving more than 44,000 patients found that certain MRI markers of cerebral small-vessel disease were associated with recurrent stroke. White-matter hyperintensities were associated with higher recurrence risk, as were cerebral microbleeds, with risk generally increasing as imaging burden increased.

These findings do not mean that an MRI finding guarantees another stroke. They show how imaging information may contribute to overall risk stratification when interpreted by clinicians.

Can Artificial Intelligence Estimate Recurrence Risk?

Researchers are increasingly evaluating statistical and machine-learning models for personalized recurrence prediction.

One example, the PRERISK study, analyzed health data from more than 36,000 stroke patients. Approximately 16.2% experienced recurrence during a median follow-up of 2.69 years. Important variables in the models included time from previous stroke, functional status, atrial fibrillation, dyslipidemia, age, diabetes, blood pressure, smoking, and other vascular factors.

This demonstrates the potential value of combining multiple variables rather than relying on a single risk factor.

But it also highlights an important limitation:

Prediction is not certainty.

An algorithm may estimate that two people have different risks, but it cannot know with certainty who will experience another stroke.

Models also need validation in populations different from the ones in which they were developed.

What Does a “10% Risk” Actually Mean?

Suppose a validated model estimates someone's five-year recurrence risk at 10%.

It does not mean:

  • The person will have another stroke.

  • A stroke will occur in exactly five years.

  • Their risk cannot change.

  • Every person with the same score has identical risk.

It means that among people sufficiently similar to the population represented by the model, approximately 10 out of 100 might experience the specified outcome during that period.

Individual outcomes remain uncertain.

This distinction is especially important when risk estimates are presented directly to patients.

Risk Can Change Over Time

Stroke risk is not necessarily fixed at the moment of hospital discharge.

Changes in factors such as:

  • Blood pressure

  • Smoking

  • Diabetes management

  • Cholesterol

  • Physical activity

  • Medication adherence

  • Detection and treatment of atrial fibrillation

may alter a person's future cardiovascular risk.

For this reason, secondary stroke prevention is an ongoing process rather than a one-time assessment. Current AHA/ASA guidance emphasizes identifying the cause of the original stroke and addressing modifiable risk factors over the long term.

Why Recurrence Tracking Can Be Useful in Rehabilitation

Recurrence prevention and rehabilitation are different clinical goals, but they are closely connected.

A rehabilitation platform may help survivors organize information such as:

  • Blood-pressure history

  • Activity patterns

  • Relevant medical history

  • Recovery progress

  • Changes in functional status

  • Questions to discuss with clinicians

When recurrence-risk estimates are provided, they should be clearly presented as informational estimates, not diagnoses or guarantees.

They should also explain which factors contributed to the estimate.

A number without context can be frightening. A number accompanied by understandable contributing factors can support a more productive discussion with a healthcare professional.

When to Seek Immediate Help

Risk prediction should never be used to decide whether new neurological symptoms are serious.

Sudden symptoms such as new facial weakness, arm weakness, speech difficulty, vision loss, severe imbalance, or other possible stroke symptoms require urgent medical evaluation.

A “low predicted risk” does not rule out an acute stroke.

Final Thoughts

Having experienced one stroke does increase the possibility of another, but there is no universal recurrence percentage that accurately describes every survivor.

Modern recurrence assessment increasingly combines clinical history, stroke mechanism, cardiovascular risk factors, imaging, and—in research settings—statistical or machine-learning models.

The most useful role of recurrence prediction is not to tell someone that another stroke will happen.

It is to help answer a better question:

“Which factors may be contributing to my risk, and what should I discuss with my healthcare team?”

Used this way, recurrence estimates can become tools for prevention rather than sources of fear.

References

  1. Berghout BP, Bos D, Koudstaal PJ, Ikram MA, Ikram MK. Risk of recurrent stroke in Rotterdam between 1990 and 2020: a population-based cohort study. The Lancet Regional Health – Europe. 2023. The study reported an overall 10-year recurrence risk of 18.0%, decreasing to 11.0% for first strokes occurring during 2010–2020.

  2. Cheung Y, et al. Clinical and Biomarker Determinants for Recurrent Stroke in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis. Neurology. 2025.

  3. Hairus S MN, et al. Cerebral Small-Vessel Disease Markers on Magnetic Resonance Imaging as Predictors of Recurrent Vascular Events and Death in Ischemic Stroke: A Systematic Review and Meta-Analysis. Journal of the American Heart Association. 2025.

  4. Monteagudo-Gimeno E, et al. PRERISK: A Personalized, Artificial Intelligence-Based and Statistically-Based Stroke Recurrence Predictor for Recurrent Stroke. 2024.

  5. Kleindorfer DO, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke. 2021.